10-Q · 2026-11-09
Aura Biosciences, Inc. shares quarterly results, emphasizing its commitment to innovation in the biological products industry.
| Name | Aura Biosciences, Inc. |
|---|---|
| CIK | 0001501796 |
| Tickers | AURA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 320271970 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (617)500-8864 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Aura Biosciences, Inc. shares quarterly results, emphasizing its commitment to innovation in the biological products industry.
Aura Biosciences, Inc. released its Q3 2026 financial results and updated its corporate presentation for investors.
388 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-128723 | 005-92997 | 261563792 | 34 | 14456 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-464008 | 005-92997 | 261563314 | 34 | 21060 | |||
| 2026-11-16 | 4 | xslF345X06/form4-11162026_101156.xml | 0001997710-26-000008 | 5585 | ||||||
| 2026-11-16 | 144 | xsl144X01/primary_doc.xml | 0001997710-26-000007 | 001-40971 | 261562919 | 33 | 11696 | |||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-007763 | 005-92997 | 261552260 | 34 | 18199 | |||
| 2026-11-09 | 10-Q | 10-Q | 0001193125-26-452636 | 001-40971 | 261533796 | 34 | 11007225 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-452620 | 001-40971 | 261533774 | 34 | 10017096 | 1 | 1 |
| 2026-10-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-003757 | 005-92997 | 261491584 | 34 | 10798 | |||
| 2026-10-01 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001470831-26-000917 | 005-92997 | 261431360 | 34 | 153229 | |||
| 2026-09-01 | 4 | xslF345X06/form4-09012026_090914.xml | 0001946505-26-000009 | 14949 | ||||||
| 2026-09-01 | 4 | xslF345X06/form4-09012026_090933.xml | 0002148785-26-000009 | 14973 | ||||||
| 2026-09-01 | 4 | xslF345X06/form4-09012026_090929.xml | 0001997710-26-000004 | 14976 | ||||||
| 2026-09-01 | 4 | xslF345X06/form4-09012026_090904.xml | 0002042910-26-000003 | 14938 | ||||||
| 2026-09-01 | 4 | xslF345X06/form4-09012026_090941.xml | 0002148701-26-000008 | 14965 | ||||||
| 2026-09-01 | S-8 | S-8 | 0001193125-26-378494 | 333-298689 | 261351289 | 33 | 587256 | 1 | 1 | |
| 2026-08-20 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002723 | 333-298228 | 261301600 | 33 | 1714 | ||
| 2026-08-18 | CORRESP | filename1.htm | 0001193125-26-355417 | 9310 | ||||||
| 2026-08-17 | UPLOAD | filename1.pdf | 0000000000-26-008094 | 333-298228 | 146690 | |||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001231919-26-000913 | 005-92997 | 261282424 | 34 | 34409 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001019056-26-000129 | 005-92997 | 261275822 | 34 | 10426 | |||
| 2026-08-12 | 3 | xslF345X06/form3-08122026_080802.xml | 0001946505-26-000006 | 9611 | ||||||
| 2026-08-12 | 3 | xslF345X06/form3-08122026_080822.xml | 0002148785-26-000005 | 9754 | ||||||
| 2026-08-12 | 3 | xslF345X06/form3-08122026_080859.xml | 0002148701-26-000005 | 9755 | ||||||
| 2026-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-004960 | 005-92997 | 261266215 | 34 | 12939 | |||
| 2026-08-11 | S-3 | S-3 | 0001193125-26-344699 | 333-298228 | 261263453 | 33 | 930215 | 1 | 1 | |
| 2026-08-11 | 10-Q | 10-Q | 0001193125-26-343429 | 001-40971 | 261260608 | 34 | 10922278 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,2.05,5.02,8.01,9.01 | 0001193125-26-343408 | 001-40971 | 261260584 | 34 | 10085318 | 1 | 1 |
| 2026-08-05 | 8-K | 8-K | 5.07 | 0001193125-26-335157 | 001-40971 | 261243742 | 34 | 181485 | 1 | 1 |
| 2026-07-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002193 | 005-92997 | 261206108 | 34 | 10848 | |||
| 2026-07-08 | 4 | 4 | 0001193125-26-298542 | 7215 | ||||||
| 2026-07-08 | 3 | 3 | 0001193125-26-298538 | 15994 | ||||||
| 2026-07-08 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-297992 | 001-40971 | 261160763 | 34 | 259548 | 1 | 1 |
| 2026-07-01 | 4 | 4 | 0001193125-26-292685 | 4981 | ||||||
| 2026-06-29 | DEF 14A | DEF 14A | 0001193125-26-288498 | 001-40971 | 261137087 | 34 | 2905733 | 1 | 1 | |
| 2026-06-17 | PRE 14A | PRE 14A | 0001193125-26-274232 | 001-40971 | 261098946 | 34 | 2922073 | 1 | 1 | |
| 2026-06-16 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-272705 | 001-40971 | 261095076 | 33 | 4598 | |||
| 2026-06-16 | 4 | 4 | 0001193125-26-272703 | 4936 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271171 | 7275 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271170 | 7312 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271168 | 10019 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271165 | 7319 | ||||||
| 2026-06-11 | 8-K | 8-K | 5.07 | 0001193125-26-267676 | 001-40971 | 261083566 | 34 | 179657 | 1 | 1 |
| 2026-05-19 | 4 | 4 | 0001580111-26-000009 | 9633 | ||||||
| 2026-05-19 | S-8 | S-8 | 0001193125-26-230896 | 333-296029 | 26999373 | 33 | 302049 | 1 | 1 | |
| 2026-05-12 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-219992 | 005-92997 | 26970206 | 34 | 129202 | |||
| 2026-05-11 | 4 | OWNERSHIP DOCUMENT | 0000950142-26-001346 | 7975 | ||||||
| 2026-05-11 | 10-Q | 10-Q | 0001193125-26-216808 | 001-40971 | 26963414 | 34 | 8848619 | 1 | 1 | |
| 2026-05-11 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000950142-26-001345 | 005-92997 | 26963386 | 34 | 9510 | |||
| 2026-05-11 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-216743 | 001-40971 | 26963137 | 34 | 24736996 | 1 | 1 |
| 2026-05-07 | 3 | 3 | 0001580111-26-000004 | 16097 | ||||||
| 2026-05-05 | 8-K | 8-K | 1.01,9.01 | 0001193125-26-206804 | 001-40971 | 26944698 | 34 | 707201 | 1 | 1 |
| 2026-05-05 | 424B5 | 424B5 | 0001193125-26-204513 | 333-278253 | 26939607 | 33 | 1524050 | |||
| 2026-05-04 | 8-K | 8-K | 1.01,2.02,8.01 | 0001193125-26-204049 | 001-40971 | 26937939 | 34 | 151238 | 1 | 1 |
| 2026-05-04 | DEFA14A | DEFA14A | 0001193125-26-202638 | 001-40971 | 26934709 | 34 | 74284 | |||
| 2026-05-04 | S-3MEF | S-3MEF | 0001193125-26-202563 | 333-295515 | 26934648 | 33 | 281058 | 1 | 1 | |
| 2026-05-04 | 424B5 | 424B5 | 0001193125-26-202458 | 333-278253 | 26934568 | 33 | 1526849 | |||
| 2026-05-04 | 8-K | 8-K | 5.02,7.01,8.01,9.01 | 0001193125-26-202414 | 001-40971 | 26934542 | 34 | 203534 | 1 | 1 |
| 2026-04-20 | ARS | ARS | 0001193125-26-164048 | 001-40971 | 26875286 | 34 | 3301964 | |||
| 2026-04-20 | DEFA14A | DEFA14A | 0001193125-26-164016 | 001-40971 | 26875207 | 34 | 309206 | |||
| 2026-04-20 | DEF 14A | DEF 14A | 0001193125-26-163933 | 001-40971 | 26875044 | 34 | 2978144 | 1 | 1 | |
| 2026-04-16 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-159580 | 001-40971 | 26868904 | 33 | 5152 | |||
| 2026-04-16 | 4 | 4 | 0001193125-26-159579 | 5384 | ||||||
| 2026-03-30 | S-8 | S-8 | 0001193125-26-130408 | 333-294724 | 26809974 | 33 | 379328 | 1 | 1 | |
| 2026-03-30 | 10-K | 10-K | 0001193125-26-130401 | 001-40971 | 26809957 | 34 | 30599008 | 1 | 1 | |
| 2026-03-30 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-130383 | 001-40971 | 26809939 | 34 | 24699067 | 1 | 1 |
| 2026-03-03 | 4 | 4 | 0001193125-26-088170 | 7196 | ||||||
| 2026-03-03 | 4 | 4 | 0001193125-26-088168 | 7268 | ||||||
| 2026-03-03 | 4 | 4 | 0001193125-26-088162 | 8185 | ||||||
| 2026-03-03 | 4 | 4 | 0001193125-26-088158 | 7221 | ||||||
| 2026-03-03 | 4 | 4 | 0001193125-26-088154 | 7207 | ||||||
| 2026-03-03 | 4 | 4 | 0001193125-26-088150 | 7183 | ||||||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001062993-26-001017 | 005-92997 | 26644905 | 34 | 19424 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-055509 | 001-40971 | 26644714 | 33 | 4550 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-055508 | 001-40971 | 26644707 | 33 | 5201 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-055507 | 001-40971 | 26644706 | 33 | 5799 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-055504 | 001-40971 | 26644701 | 33 | 5759 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-055502 | 001-40971 | 26644697 | 33 | 5867 | |||
| 2026-02-17 | 4 | 4 | 0001193125-26-055499 | 5247 | ||||||
| 2026-02-17 | 4 | 4 | 0001193125-26-055497 | 5271 | ||||||
| 2026-02-17 | 4 | 4 | 0001193125-26-055496 | 5257 | ||||||
| 2026-02-17 | 4 | 4 | 0001193125-26-055494 | 5234 | ||||||
| 2026-02-17 | 4 | 4 | 0001193125-26-055487 | 6234 | ||||||
| 2026-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001231919-26-000155 | 005-92997 | 26634873 | 34 | 47145 | |||
| 2026-01-20 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-016944 | 001-40971 | 26544263 | 33 | 5154 | |||
| 2026-01-20 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-016941 | 001-40971 | 26544259 | 33 | 5262 | |||
| 2026-01-20 | 4 | 4 | 0001193125-26-016939 | 4713 | ||||||
| 2026-01-20 | 4 | 4 | 0001193125-26-016938 | 6234 | ||||||
| 2025-11-17 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-284880 | 001-40971 | 251492278 | 33 | 4589 | |||
| 2025-11-17 | 4 | 4 | 0001193125-25-284878 | 5258 | ||||||
| 2025-11-13 | 10-Q | 10-Q | 0001193125-25-278817 | 001-40971 | 251475379 | 34 | 9860375 | 1 | 1 | |
| 2025-11-13 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-25-278810 | 001-40971 | 251475357 | 34 | 22827386 | 1 | 1 |
| 2025-10-29 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-256625 | 001-40971 | 251430897 | 33 | 5156 | |||
| 2025-10-29 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-256622 | 001-40971 | 251430894 | 33 | 4652 | |||
| 2025-10-29 | 4 | 4 | 0001193125-25-256620 | 4713 | ||||||
| 2025-10-29 | 4 | 4 | 0001193125-25-256619 | 5713 | ||||||
| 2025-10-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-002503 | 005-92997 | 251401766 | 34 | 10707 | |||
| 2025-10-16 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-241623 | 001-40971 | 251398523 | 33 | 4600 | |||
| 2025-10-16 | 4 | 4 | 0001193125-25-241622 | 4751 | ||||||
| 2025-08-18 | 4 | 4 | 0000950170-25-109767 | 29131 | ||||||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-005973 | 001-40971 | 251228162 | 33 | 4606 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-021797 | 005-92997 | 251217153 | 34 | 48941 | |||
| 2025-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-004722 | 005-92997 | 251213704 | 34 | 18567 | |||
| 2025-08-13 | 10-Q | 10-Q | 0001193125-25-179426 | 001-40971 | 251208979 | 34 | 9703748 | 1 | 1 | |
| 2025-08-13 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-25-179418 | 001-40971 | 251208959 | 34 | 26052339 | 1 | 1 |
| 2025-07-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002483 | 005-92997 | 251128439 | 34 | 10759 | |||
| 2025-06-18 | 4 | 4 | 0000950170-25-087891 | 20201 | ||||||
| 2025-06-18 | 4 | 4 | 0000950170-25-087890 | 9882 | ||||||
| 2025-06-18 | 4 | 4 | 0000950170-25-087889 | 20199 | ||||||
| 2025-06-18 | 8-K | 8-K | 5.07 | 0000950170-25-087885 | 001-40971 | 251056928 | 34 | 179890 | 1 | 1 |
| 2025-06-04 | 4 | 4 | 0000950170-25-081616 | 7264 | ||||||
| 2025-06-04 | 4 | 4 | 0000950170-25-081615 | 9409 | ||||||
| 2025-05-23 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-014432 | 005-92997 | 25982218 | 34 | 82257 | |||
| 2025-05-20 | 4 | 4 | 0000950170-25-075412 | 24152 | ||||||
| 2025-05-20 | 4 | 4 | 0000950170-25-075403 | 8575 | ||||||
| 2025-05-19 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000902664-25-002479 | 005-92997 | 25964542 | 34 | 9440 | |||
| 2025-05-16 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-073664 | 001-40971 | 25960198 | 33 | 4593 | |||
| 2025-05-16 | 3 | 3 | 0000950170-25-073661 | 17934 | ||||||
| 2025-05-16 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-25-121677 | 001-40971 | 25959081 | 34 | 22886498 | 1 | 1 |
| 2025-05-16 | 424B5 | 424B5 | 0001193125-25-121280 | 333-278253 | 25956917 | 33 | 816880 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001344676-25-000018 | 005-92997 | 25950172 | 34 | 10067 | |||
| 2025-05-15 | 424B5 | 424B5 | 0001193125-25-120252 | 333-278253 | 25948524 | 33 | 818943 | |||
| 2025-05-15 | 10-Q | 10-Q | 0000950170-25-071907 | 001-40971 | 25948359 | 34 | 8368392 | 1 | 1 | |
| 2025-05-15 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-25-071839 | 001-40971 | 25948338 | 34 | 428966 | 1 | 1 |
| 2025-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001580642-25-003115 | 005-92997 | 25944880 | 34 | 11081 | |||
| 2025-05-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001580642-25-003100 | 005-92997 | 25941554 | 34 | 11113 | |||
| 2025-04-24 | ARS | ARS | 0000950170-25-058076 | 001-40971 | 25867593 | 34 | 2995715 | |||
| 2025-04-24 | DEFA14A | DEFA14A | 0000950170-25-058070 | 001-40971 | 25867568 | 34 | 295015 | |||
| 2025-04-24 | DEF 14A | DEF 14A | 0000950170-25-058062 | 001-40971 | 25867511 | 34 | 2982478 | 1 | 1 | |
| 2025-04-16 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-054957 | 001-40971 | 25843994 | 33 | 5752 | |||
| 2025-04-16 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-054956 | 001-40971 | 25843993 | 33 | 4548 | |||
| 2025-04-16 | 4 | 4 | 0000950170-25-054954 | 5253 | ||||||
| 2025-04-16 | 4 | 4 | 0000950170-25-054953 | 17388 | ||||||
| 2025-04-11 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-002448 | 005-92997 | 25833804 | 34 | 17175 | |||
| 2025-04-02 | 4 | 4 | 0000950170-25-049279 | 7059 | ||||||
| 2025-04-02 | 3 | 3 | 0000950170-25-049273 | 15091 | ||||||
| 2025-04-02 | 8-K | 8-K | 5.02,9.01 | 0000950170-25-048880 | 001-40971 | 25802130 | 34 | 206686 | 1 | 1 |
| 2025-03-24 | S-8 | S-8 | 0000950170-25-043965 | 333-286061 | 25765075 | 33 | 182434 | |||
| 2025-03-24 | 10-K | 10-K | 0000950170-25-043943 | 001-40971 | 25764941 | 34 | 35278468 | 1 | 1 | |
| 2025-03-24 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-25-043809 | 001-40971 | 25764078 | 34 | 28572917 | 1 | 1 |
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-022660 | 001-40971 | 25636800 | 33 | 4604 | |||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-022659 | 001-40971 | 25636799 | 33 | 5202 | |||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-022657 | 001-40971 | 25636797 | 33 | 5159 | |||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-022656 | 001-40971 | 25636796 | 33 | 5272 | |||
| 2025-02-18 | 4 | 4 | 0000950170-25-022655 | 4756 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022654 | 4740 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022653 | 4742 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022651 | 6243 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001580642-25-001009 | 005-92997 | 25625325 | 34 | 14004 | |||
| 2025-02-04 | 4 | 4 | 0000950170-25-013830 | 8734 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013829 | 7226 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013828 | 7213 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013827 | 7197 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013825 | 7210 | ||||||
| 2025-01-21 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-007497 | 001-40971 | 25543700 | 33 | 5270 | |||
| 2025-01-21 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-007496 | 001-40971 | 25543699 | 33 | 5157 | |||
| 2025-01-21 | 4 | 4 | 0000950170-25-007495 | 6243 | ||||||
| 2025-01-21 | 4 | 4 | 0000950170-25-007494 | 5256 | ||||||
| 2025-01-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001019056-25-000007 | 005-92997 | 25508587 | 34 | 18773 | |||
| 2025-01-03 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001019056-25-000005 | 005-92997 | 25507591 | 34 | 18930 | |||
| 2024-11-18 | 4 | 4 | 0000950170-24-128206 | 21511 | ||||||
| 2024-11-18 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-128172 | 001-40971 | 241472984 | 33 | 4527 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119334 | 005-92997 | 241464790 | 34 | 65815 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-118966 | 005-92997 | 241462681 | 34 | 136575 | |||
| 2024-11-12 | 10-Q | 10-Q | 0000950170-24-125428 | 001-40971 | 241448383 | 34 | 8691287 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-24-125390 | 001-40971 | 241448172 | 34 | 21304234 | 1 | 1 |
| 2024-11-12 | SC 13G/A | p24-3041sc13ga.htm | 0000902664-24-006403 | 005-92997 | 241444210 | 34 | 71272 | |||
| 2024-11-08 | SC 13G | us05153u1079_110824.txt | 0002012383-24-003494 | 005-92997 | 241439622 | 34 | 13589 | |||
| 2024-10-29 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-118485 | 001-40971 | 241407129 | 33 | 4556 | |||
| 2024-10-29 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-118482 | 001-40971 | 241407125 | 33 | 5287 | |||
| 2024-10-29 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-118481 | 001-40971 | 241407124 | 33 | 5221 | |||
| 2024-10-29 | 4 | 4 | 0000950170-24-118478 | 6246 | ||||||
| 2024-10-29 | 4 | 4 | 0000950170-24-118475 | 5259 | ||||||
| 2024-10-29 | 3 | 3 | 0000950170-24-118473 | 31900 | ||||||
| 2024-10-22 | SC 13G | us05153u1079_102224.txt | 0002012383-24-001608 | 005-92997 | 241387334 | 34 | 13577 | |||
| 2024-10-21 | 4 | 4 | 0000950170-24-116029 | 30519 | ||||||
| 2024-10-18 | 4 | 4 | 0000950170-24-115729 | 9680 | ||||||
| 2024-10-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007810 | 001-40971 | 241381000 | 33 | 4716 | |||
| 2024-10-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007809 | 001-40971 | 241380999 | 33 | 4810 | |||
| 2024-10-17 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-238959 | 001-40971 | 241378322 | 34 | 18485368 | 1 | 1 |
| 2024-10-16 | 4 | 4 | 0000950170-24-115150 | 16881 | ||||||
| 2024-10-16 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-115148 | 001-40971 | 241375736 | 33 | 4686 | |||
| 2024-10-01 | 4 | 4 | 0000950170-24-110933 | 22706 | ||||||
| 2024-09-27 | 8-K | 8-K | 5.02 | 0001193125-24-227950 | 001-40971 | 241334882 | 34 | 154447 | 1 | 1 |
| 2024-09-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-217619 | 001-40971 | 241293859 | 34 | 14116189 | 1 | 1 |
| 2024-08-08 | 10-Q | 10-Q | 0000950170-24-093308 | 001-40971 | 241186010 | 34 | 8383691 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-24-093298 | 001-40971 | 241185972 | 34 | 17977849 | 1 | 1 |
| 2024-06-24 | 4 | 4 | 0000950170-24-076715 | 7191 | ||||||
| 2024-06-24 | 4 | 4 | 0000950170-24-076713 | 7184 | ||||||
| 2024-06-24 | 4 | 4 | 0000950170-24-076707 | 9891 | ||||||
| 2024-06-21 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-24-165656 | 001-40971 | 241060208 | 34 | 174399 | 1 | 1 |
| 2024-06-14 | DEFA14A | DEFA14A | 0001193125-24-161687 | 001-40971 | 241045518 | 34 | 158890 | |||
| 2024-06-14 | 10-K/A | 10-K/A | 0001193125-24-161680 | 001-40971 | 241045445 | 34 | 527942 | 1 | 1 | |
| 2024-06-04 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-154364 | 001-40971 | 241019228 | 34 | 12669173 | 1 | 1 |
| 2024-05-09 | 10-Q | 10-Q | 0000950170-24-056265 | 001-40971 | 24928531 | 34 | 7679448 | 1 | 1 | |
| 2024-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-056252 | 001-40971 | 24928498 | 34 | 344290 | 1 | 1 |
| 2024-04-25 | ARS | ARS | 0001193125-24-113891 | 001-40971 | 24876334 | 34 | 3108181 | |||
| 2024-04-25 | DEFA14A | DEFA14A | 0001193125-24-113884 | 001-40971 | 24876296 | 34 | 797761 | |||
| 2024-04-25 | DEF 14A | DEF 14A | 0001193125-24-113878 | 001-40971 | 24876232 | 34 | 447226 | |||
| 2024-04-15 | 8-K | 8-K | 5.02 | 0001193125-24-096204 | 001-40971 | 24844717 | 34 | 144136 | 1 | 1 |
| 2024-04-15 | PRE 14A | PRE 14A | 0001193125-24-096191 | 001-40971 | 24844679 | 34 | 448608 | |||
| 2024-04-05 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-04-05 16:05:00 | 9999999995-24-000875 | 333-278253 | 24827978 | 33 | 1720 | ||
| 2024-04-04 | 4 | 4 | 0000950170-24-041803 | 7180 | ||||||
| 2024-04-04 | 3 | 3 | 0000950170-24-041796 | 15374 | ||||||
| 2024-04-03 | CORRESP | filename1.htm | 0001193125-24-086018 | 6117 | ||||||
| 2024-04-03 | UPLOAD | filename1.pdf | 0000000000-24-003569 | 333-278253 | 40269 | |||||
| 2024-03-27 | S-3 | S-3 | 0001193125-24-078268 | 333-278253 | 24785889 | 33 | 1092481 | |||
| 2024-03-27 | S-8 | S-8 | 0001193125-24-078257 | 333-278252 | 24785830 | 33 | 67187 | |||
| 2024-03-27 | 10-K | 10-K | 0000950170-24-036814 | 001-40971 | 24785757 | 34 | 19432728 | 1 | 1 | |
| 2024-03-27 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-036811 | 001-40971 | 24785750 | 34 | 351692 | 1 | 1 |
| 2024-03-25 | 3 | 3 | 0000950170-24-035901 | 18141 | ||||||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-001794 | 001-40971 | 24716465 | 33 | 16453 | |||
| 2024-02-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-001343 | 001-40971 | 24671542 | 33 | 14723 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023933 | 005-92997 | 24639960 | 34 | 137998 | |||
| 2024-02-07 | SC 13G/A | AURA BIOSCIENCES, INC. | 0000902664-24-001181 | 005-92997 | 24602209 | 34 | 95691 | |||
| 2024-02-02 | 4 | 4 | 0000950170-24-010461 | 7214 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010462 | 7196 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010460 | 8195 | ||||||
| 2024-01-24 | 4 | 4 | 0000950170-24-006988 | 6244 | ||||||
| 2024-01-24 | 4 | 4 | 0000950170-24-006987 | 5242 | ||||||
| 2024-01-24 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-006963 | 001-40971 | 24556381 | 33 | 5887 | |||
| 2024-01-24 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-006962 | 001-40971 | 24556382 | 33 | 6450 | |||
| 2024-01-08 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000190 | 001-40971 | 24520203 | 33 | 12034 | |||
| 2024-01-08 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-003887 | 001-40971 | 24518341 | 34 | 5149863 | 1 | 1 |
| 2024-01-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000022 | 001-40971 | 24502853 | 33 | 11313 | |||
| 2023-12-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-006144 | 001-40971 | 231490802 | 33 | 5367 | |||
| 2023-12-11 | SC 13G/A | SC 13G/A | 0001580642-23-006643 | 005-92997 | 231478933 | 34 | 56209 | |||
| 2023-11-09 | 4 | 4 | 0000950170-23-062214 | 13917 | ||||||
| 2023-11-09 | 4 | xslF345X05/ownership.xml | 0000902664-23-005429 | 7581 | ||||||
| 2023-11-09 | SC 13D/A | AURA BIOSCIENCES, INC. | 0000902664-23-005428 | 005-92997 | 231393174 | 34 | 85058 | |||
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-062097 | 001-40971 | 231392809 | 34 | 9610953 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 1.01,2.02,9.01 | 0000950170-23-062074 | 001-40971 | 231392612 | 34 | 1017457 | 1 | 1 |
| 2023-11-07 | 4 | 4 | 0000950170-23-060499 | 9593 | ||||||
| 2023-11-07 | 4 | 4 | 0000950170-23-060493 | 8592 | ||||||
| 2023-11-07 | 424B5 | 424B5 | 0001193125-23-272529 | 333-268105 | 231384865 | 33 | 733315 | |||
| 2023-11-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-004765 | 001-40971 | 231380271 | 33 | 5945 | |||
| 2023-11-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-004757 | 001-40971 | 231380241 | 33 | 5317 | |||
| 2023-11-06 | 424B5 | 424B5 | 0001193125-23-271382 | 333-268105 | 231380186 | 33 | 736158 | |||
| 2023-11-06 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-271351 | 001-40971 | 231379881 | 34 | 16551190 | 1 | 1 |
| 2023-11-03 | 4 | 4 | 0000950170-23-058900 | 7124 | ||||||
| 2023-11-03 | 144 | xsl144X01/primary_doc.xml | 0000950170-23-058843 | 001-40971 | 231376550 | 33 | 4684 | |||
| 2023-11-03 | 144 | xsl144X01/primary_doc.xml | 0000950170-23-058842 | 001-40971 | 231376507 | 33 | 4612 | |||
| 2023-11-03 | 144 | xsl144X01/primary_doc.xml | 0000950170-23-058841 | 001-40971 | 231376501 | 33 | 5086 | |||
| 2023-11-01 | 4 | 4 | 0000950170-23-057643 | 5289 | ||||||
| 2023-11-01 | 4 | 4 | 0000950170-23-057640 | 6287 | ||||||
| 2023-10-23 | 3 | 3 | 0000950170-23-054690 | 14671 | ||||||
| 2023-10-05 | 4 | 4 | 0000950170-23-052244 | 9065 | ||||||
| 2023-10-02 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-249055 | 001-40971 | 231299756 | 34 | 195049 | 1 | 1 |
| 2023-08-09 | 10-Q | 10-Q | 0000950170-23-040138 | 001-40971 | 231153342 | 34 | 9765169 | 1 | 1 | |
| 2023-08-09 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-23-040136 | 001-40971 | 231153331 | 34 | 17357480 | 1 | 1 |
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-015209 | 5328 | ||||||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-015206 | 5342 | ||||||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-015205 | 5405 | ||||||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-015203 | 5321 | ||||||
| 2023-06-07 | 144 | xsl144X01/primary_doc.xml | 0001972362-23-000319 | 001-40971 | 231000088 | 33 | 4650 | |||
| 2023-06-07 | 8-K | 8-K | 5.07 | 0001193125-23-162617 | 001-40971 | 23999622 | 34 | 149738 | 1 | 1 |
| 2023-06-02 | 144 | xsl144X01/primary_doc.xml | 0001972362-23-000287 | 001-40971 | 23990785 | 33 | 4052 | |||
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-021302 | 001-40971 | 23911471 | 34 | 9137970 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-23-021284 | 001-40971 | 23911373 | 34 | 21027831 | 1 | 1 |
| 2023-04-25 | ARS | ARS | 0001193125-23-115308 | 001-40971 | 23844968 | 34 | 3716388 | |||
| 2023-04-25 | DEFA14A | DEFA14A | 0001193125-23-115294 | 001-40971 | 23844912 | 34 | 336382 | |||
| 2023-04-25 | DEF 14A | DEF 14A | 0001193125-23-115288 | 001-40971 | 23844874 | 34 | 689356 | |||
| 2023-04-04 | 8-K | 8-K | 5.02 | 0001193125-23-090316 | 001-40971 | 23795105 | 34 | 143595 | 1 | 1 |
| 2023-03-15 | S-8 | S-8 | 0001193125-23-071431 | 333-270571 | 23735866 | 33 | 65892 | |||
| 2023-03-15 | 10-K | 10-K | 0000950170-23-008166 | 001-40971 | 23735586 | 34 | 22873963 | 1 | 1 | |
| 2023-03-15 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-008163 | 001-40971 | 23735573 | 34 | 446806 | 1 | 1 |
| 2023-02-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-040742 | 001-40971 | 23637203 | 34 | 17829016 | 1 | 1 |
| 2023-02-14 | SC 13G | SC 13G | 0001580642-23-000861 | 005-92997 | 23626460 | 34 | 58467 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-020726 | 005-92997 | 23622639 | 34 | 137991 | |||
| 2023-02-10 | SC 13G/A | SC 13G/A | 0001193125-23-032710 | 005-92997 | 23612732 | 34 | 62155 | |||
| 2023-02-09 | SC 13G/A | AURA BIOSCIENCES, INC. | 0000902664-23-001331 | 005-92997 | 23602216 | 34 | 103117 | |||
| 2023-01-23 | 4 | FORM 4 SUBMISSION | 0000899243-23-002437 | 7358 | ||||||
| 2023-01-23 | 4 | FORM 4 SUBMISSION | 0000899243-23-002436 | 7375 | ||||||
| 2023-01-23 | 4 | FORM 4 SUBMISSION | 0000899243-23-002434 | 8337 | ||||||
| 2023-01-23 | 4 | FORM 4 SUBMISSION | 0000899243-23-002433 | 7397 | ||||||
| 2023-01-20 | SC 13G/A | SC 13G/A | 0001104659-23-005392 | 005-92997 | 23540946 | 34 | 86451 | |||
| 2023-01-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-001324 | 10034 | ||||||
| 2023-01-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-003670 | 001-40971 | 23516006 | 34 | 15404798 | 1 | 1 |
| 2022-12-30 | 4 | FORM 4 SUBMISSION | 0000899243-22-039594 | 6640 | ||||||
| 2022-12-15 | 4 | FORM 4 SUBMISSION | 0000899243-22-038695 | 6642 | ||||||
| 2022-12-15 | SC 13G | AURA BIOSCIENCES, INC. | 0000902664-22-005182 | 005-92997 | 221465332 | 34 | 104933 | |||
| 2022-12-07 | 4 | xslF345X03/ownership.xml | 0000902664-22-005061 | 7562 | ||||||
| 2022-12-07 | SC 13D/A | AURA BIOSCIENCES, INC. | 0000902664-22-005060 | 005-92997 | 221450485 | 34 | 51098 | |||
| 2022-12-05 | 8-K | 8-K | 1.01,9.01 | 0001193125-22-298535 | 001-40971 | 221445812 | 34 | 500030 | 1 | 1 |
| 2022-12-01 | 424B5 | 424B5 | 0001193125-22-296622 | 333-268105 | 221439414 | 33 | 789875 | |||
| 2022-11-30 | 424B5 | 424B5 | 0001193125-22-295399 | 333-268105 | 221435764 | 33 | 793526 | |||
| 2022-11-30 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-295368 | 001-40971 | 221435594 | 34 | 17336003 | 1 | 1 |
| 2022-11-10 | 10-Q | 10-Q | 0000950170-22-024150 | 001-40971 | 221374906 | 34 | 10562242 | 1 | 1 | |
| 2022-11-10 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-22-024145 | 001-40971 | 221374885 | 34 | 537192 | 1 | 1 |
| 2022-11-07 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-11-07 16:00:00 | 9999999995-22-003223 | 333-268105 | 221367036 | 33 | 1672 | ||
| 2022-11-03 | CORRESP | filename1.htm | 0001193125-22-276950 | 6304 | ||||||
| 2022-11-03 | UPLOAD | filename1.pdf | 0000000000-22-011989 | 40146 | ||||||
| 2022-11-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-034838 | 5348 | ||||||
| 2022-11-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-034837 | 5386 | ||||||
| 2022-11-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-034836 | 6322 | ||||||
| 2022-11-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-034834 | 5365 | ||||||
| 2022-11-01 | S-3 | S-3 | 0001193125-22-275062 | 333-268105 | 221351487 | 33 | 1285950 | |||
| 2022-10-03 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-22-256110 | 001-40971 | 221285919 | 34 | 23573029 | 1 | 1 |
| 2022-09-28 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-252714 | 001-40971 | 221272856 | 34 | 174686 | 1 | 1 |
| 2022-08-11 | 10-Q | 10-Q | 0000950170-22-016911 | 001-40971 | 221156303 | 34 | 12905340 | 1 | 1 | |
| 2022-08-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-016905 | 001-40971 | 221156253 | 34 | 507079 | 1 | 1 |
| 2022-06-30 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-185580 | 001-40971 | 221056521 | 34 | 173062 | 1 | 1 |
| 2022-06-22 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-178857 | 001-40971 | 221032746 | 34 | 15562745 | 1 | 1 |
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0000899243-22-023131 | 5386 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0000899243-22-023128 | 8628 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0000899243-22-023127 | 5302 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0000899243-22-023125 | 5309 | ||||||
| 2022-06-15 | 8-K | 8-K | 5.07 | 0001193125-22-174863 | 001-40971 | 221018439 | 34 | 150980 | 1 | 1 |
| 2022-06-14 | 4 | FORM 4 SUBMISSION | 0000899243-22-022456 | 13118 | ||||||
| 2022-05-27 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-161235 | 001-40971 | 22971831 | 34 | 177410 | 1 | 1 |
| 2022-05-18 | 8-K | 8-K | 1.01,2.03 | 0001193125-22-154031 | 001-40971 | 22939096 | 34 | 146252 | 1 | 1 |
| 2022-05-12 | 10-Q | 10-Q | 0000950170-22-009719 | 001-40971 | 22918421 | 34 | 8801517 | 1 | 1 | |
| 2022-05-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-009706 | 001-40971 | 22918298 | 34 | 419220 | 1 | 1 |
| 2022-04-28 | DEFA14A | DEFA14A | 0001193125-22-127660 | 001-40971 | 22867002 | 34 | 414750 | |||
| 2022-04-28 | DEF 14A | DEF 14A | 0001193125-22-127614 | 001-40971 | 22866829 | 34 | 738579 | |||
| 2022-03-23 | S-8 | S-8 | 0001193125-22-082858 | 333-263801 | 22763852 | 33 | 61290 | |||
| 2022-03-23 | 10-K | 10-K | 0000950170-22-004425 | 001-40971 | 22763511 | 34 | 11989177 | 1 | 1 | |
| 2022-03-23 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-004419 | 001-40971 | 22763447 | 34 | 395310 | 1 | 1 |
| 2022-02-14 | SC 13G/A | AURA BIOSCIENCES, INC. | 0001104659-22-021314 | 005-92997 | 22624837 | 34 | 139792 | |||
| 2022-02-14 | SC 13G | FORM SC 13G | 0001062993-22-003816 | 005-92997 | 22623290 | 34 | 65439 | |||
| 2022-02-10 | SC 13G/A | SC 13G/A | 0001193125-22-034542 | 005-92997 | 22614551 | 34 | 65270 | |||
| 2022-01-26 | SC 13G | SC 13G | 0001193125-22-018285 | 005-92997 | 22557909 | 34 | 66188 | |||
| 2021-11-24 | 10-Q | 10-Q | 0000950170-21-004908 | 001-40971 | 211447032 | 34 | 9539670 | 1 | 1 | |
| 2021-11-24 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-004906 | 001-40971 | 211446892 | 34 | 510575 | 1 | 1 |
| 2021-11-12 | SC 13G | SC 13G | 0001104659-21-138116 | 005-92997 | 211404051 | 34 | 85957 | |||
| 2021-11-12 | SC 13G | SC 13G | 0001104659-21-138044 | 005-92997 | 211403449 | 34 | 137449 | |||
| 2021-11-10 | SC 13D | SC 13D | 0001193125-21-325850 | 005-92997 | 211396222 | 34 | 141736 | |||
| 2021-11-10 | SC 13G | SC 13G | 0001193125-21-325763 | 005-92997 | 211396028 | 34 | 57885 | |||
| 2021-11-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-043033 | 32137 | ||||||
| 2021-11-04 | SC 13D | AURA BIOSCIENCES, INC. | 0000902664-21-004741 | 005-92997 | 211380922 | 34 | 69233 | |||
| 2021-11-04 | 4 | xslF345X03/ownership.xml | 0000902664-21-004738 | 11947 | ||||||
| 2021-11-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-042362 | 10532 | ||||||
| 2021-11-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-042361 | 7530 | ||||||
| 2021-11-02 | 8-K | 8-K | 5.03,9.01 | 0001193125-21-316929 | 001-40971 | 211371236 | 34 | 20432 | ||
| 2021-11-01 | 424B4 | 424B4 | 0001193125-21-314667 | 333-260156 | 211365550 | 33 | 8636737 | |||
| 2021-10-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-042095 | 5241 | ||||||
| 2021-10-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-042094 | 7411 | ||||||
| 2021-10-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-042090 | 8347 | ||||||
| 2021-10-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-042089 | 7387 | ||||||
| 2021-10-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-042087 | 5227 | ||||||
| 2021-10-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-042083 | 7394 | ||||||
| 2021-10-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-042080 | 5304 | ||||||
| 2021-10-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-042078 | 7413 | ||||||
| 2021-10-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-042075 | 5220 | ||||||
| 2021-10-29 | S-8 | S-8 | 0001193125-21-313316 | 333-260589 | 211363233 | 33 | 318354 | |||
| 2021-10-28 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-10-28 16:00:00 | 9999999995-21-004081 | 333-260156 | 211360474 | 33 | 1680 | ||
| 2021-10-28 | S-1MEF | S-1MEF | 0001193125-21-311860 | 333-260574 | 211360241 | 33 | 48736 | |||
| 2021-10-28 | 3 | xslF345X02/ownership.xml | 0000902664-21-004649 | 7364 | ||||||
| 2021-10-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-041974 | 12304 | ||||||
| 2021-10-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-041968 | 13408 | ||||||
| 2021-10-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-041967 | 21708 | ||||||
| 2021-10-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-041963 | 7494 | ||||||
| 2021-10-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-041961 | 8641 | ||||||
| 2021-10-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-041958 | 7407 | ||||||
| 2021-10-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-041957 | 9880 | ||||||
| 2021-10-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-041955 | 8657 | ||||||
| 2021-10-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-041954 | 11704 | ||||||
| 2021-10-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-041952 | 7404 | ||||||
| 2021-10-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-041951 | 18086 | ||||||
| 2021-10-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-041946 | 8764 | ||||||
| 2021-10-28 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-005591 | 274006 | ||||||
| 2021-10-28 | CERT | 8A_Cert_AURA.pdf | 0001354457-21-001235 | 001-40971 | 211357516 | 34 | 217020 | |||
| 2021-10-26 | 8-A12B | 8-A12B | 0001193125-21-307948 | 001-40971 | 211348408 | 34 | 14350 | |||
| 2021-10-26 | CORRESP | filename1.htm | 0001193125-21-307939 | 10828 | ||||||
| 2021-10-26 | CORRESP | filename1.htm | 0001193125-21-307936 | 6968 | ||||||
| 2021-10-25 | CORRESP | filename1.htm | 0001193125-21-305947 | 15285 | ||||||
| 2021-10-25 | S-1/A | S-1/A | 0001193125-21-305934 | 333-260156 | 211342081 | 33 | 10508922 | |||
| 2021-10-13 | UPLOAD | filename1.pdf | 0000000000-21-012395 | 43930 | ||||||
| 2021-10-08 | CORRESP | filename1.htm | 0001193125-21-295546 | 22378 | ||||||
| 2021-10-08 | S-1 | S-1 | 0001193125-21-295543 | 333-260156 | 211315750 | 33 | 11125974 | |||
| 2021-09-27 | UPLOAD | filename1.pdf | 0000000000-21-011723 | 46899 | ||||||
| 2021-09-21 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-004821 | 276018 | ||||||
| 2021-09-20 | DRS/A | filename1.htm | 0000950123-21-012472 | 377-05331 | 211261867 | 33 | 10103718 | |||
| 2021-09-17 | DRSLTR | filename1.htm | 0000950123-21-012473 | 36731 | ||||||
| 2021-09-10 | UPLOAD | filename1.pdf | 0000000000-21-011050 | 55232 | ||||||
| 2021-08-10 | DRS | filename1.htm | 0000950123-21-009996 | 377-05331 | 211157739 | 33 | 9316483 | |||
| 2021-04-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001501796-21-000001 | 021-394732 | 21807414 | 33 | 9897 | ||
| 2020-07-09 | D | xslFormDX01/primary_doc.xml | 06b | 0001501796-20-000002 | 021-370627 | 201020963 | 33 | 12403 | ||
| 2019-04-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001501796-19-000001 | 021-337166 | 19745452 | 33 | 13300 | ||
| 2018-12-13 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001501796-18-000002 | 021-302255 | 181232895 | 33 | 12626 | ||
| 2018-01-03 | D | xslFormDX01/primary_doc.xml | 06b | 0001501796-18-000001 | 021-302255 | 18505017 | 33 | 12533 | ||
| 2017-11-02 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001501796-17-000001 | 021-271656 | 171171342 | 33 | 13529 | ||
| 2016-09-30 | D | xslFormDX01/primary_doc.xml | 06b | 0001501796-16-000004 | 021-271656 | 161913001 | 33 | 14263 | ||
| 2015-03-05 | D | xslFormDX01/primary_doc.xml | 06c | 0001501796-15-000001 | 021-235305 | 15677372 | 33 | 12779 | ||
| 2014-08-14 | D | xslFormDX01/primary_doc.xml | 06c | 0001501796-14-000002 | 021-222909 | 141040240 | 33 | 10849 | ||
| 2014-01-08 | D | xslFormDX01/primary_doc.xml | 06c | 0001501796-14-000001 | 021-209519 | 14515661 | 33 | 10854 | ||
| 2012-12-26 | D | xslFormDX01/primary_doc.xml | 06 | 0001501796-12-000001 | 021-188934 | 121284062 | 33 | 10061 | ||
| 2011-08-26 | D | xslFormDX01/primary_doc.xml | 06 | 0001501796-11-000001 | 021-164993 | 111058071 | 33 | 10085 | ||
| 2010-09-21 | D | xslFormDX01/primary_doc.xml | 06 | 0001501796-10-000001 | 021-148022 | 101082879 | 33 | 10522 |
One latest value per concept from companyfacts (219 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 104.07M | 2026-11-04 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 321.00M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 1,083.24 | 2026-09-01 | S-8 | 2026-09-01 | 0001193125-26-378494 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 1,083.24 | 2026-09-01 | S-8 | 2026-09-01 | 0001193125-26-378494 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 7.84M | 2026-09-01 | S-8 | 2026-09-01 | 0001193125-26-378494 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-09-01 | S-8 | 2026-09-01 | 0001193125-26-378494 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-08-07 | S-3 | 2026-08-11 | 0001193125-26-344699 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 7.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 266,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 7.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 919.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 27,000 | 2025-01-01 | 2025-03-31 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001193125-25-278817 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 4.92M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 21.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 27.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | AreaOfRealEstateProperty | Area of Real Estate Property | sqft | 4,516 | 2021-03-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008166 | |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | Assets | Assets | USD | 321.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 303.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 1.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 256.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value | USD | 30.10M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125428 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 255.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 7,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343429 |
| us-gaap | Cash | Cash | USD | 149.06M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0000950170-22-004425 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 41.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 144.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 42.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 42.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -17.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -9.39M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043943 |
| us-gaap | CashCollateralForBorrowedSecurities | Cash Collateral for Borrowed Securities | USD | 20,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0000950170-22-004425 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 11.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 11.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 103.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 103.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -112.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 137,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-036814 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 30,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 108,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 78,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 700,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 400,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 1.58M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-24 | 0000950170-21-004908 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 1.60M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-24 | 0000950170-21-004908 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 8,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0000950170-22-004425 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 150.55M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 24.44M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 84.24M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 993,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 31.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 3.01M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 1.02M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-036814 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 145.73M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 4.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 266,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | Depreciation | Depreciation | USD | 785,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | DividendsCommonStockStock | Dividends, Common Stock, Stock | USD | 0 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0000950170-22-004425 |
| us-gaap | DividendsPreferredStock | Dividends, Preferred Stock | USD | 10.94M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008166 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.22 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.44 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009719 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.22 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.001 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.331 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.017 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.036 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043943 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.025 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | -247,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 27.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | -16,000 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-11 | 0000950170-22-016911 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009719 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009719 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-11 | 0000950170-22-016911 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009719 |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 15,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008166 |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 11,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008166 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.079 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008166 | |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | 208,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043943 |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | -9,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008166 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043943 |
| us-gaap | GainLossOnTerminationOfLease | Gain (Loss) on Termination of Lease | USD | -296,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-036814 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 34.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -106.91M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -111.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 828,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 100,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 77,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 35.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -22.28M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 1.79M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 124,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 78,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | -2.73M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 173,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 2.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 696,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | 367,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | InterestIncomeExpenseAfterProvisionForLoanLoss | Interest Income (Expense), after Provision for Loan Loss | USD | 6.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | InterestReceivable | Interest Receivable | USD | 1.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | LeaseCost | Lease, Cost | USD | 4.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 21.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 6.28M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 3.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 3.83M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 3.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 3.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 3.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 866,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 5.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | Liabilities | Liabilities | USD | 34.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 321.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 21.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 255.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss | USD | 1.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 242.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -171.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -88.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -111.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 6.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | OperatingCostsAndExpenses | Operating Costs and Expenses | USD | 118.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -118.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 2.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 4,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0000950170-22-004425 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 16.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 3.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 12.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 2.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 14.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.107 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 146,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 851,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 1.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -1.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | -247,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -1.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | OtherExpenses | Other Expenses | USD | 11,000 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-11 | 0000950170-22-016911 |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 9,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009719 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 172,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | OtherOperatingActivitiesCashFlowStatement | Other Operating Activities, Cash Flow Statement | USD | 27,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-071907 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 39.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 516,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 1.42M | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024150 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 269.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 203,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | PreferredStockConvertibleConversionRatio | PreferredStockConvertibleConversionRatio | pure | 1 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-24 | 0000950170-21-004908 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 5.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 435,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043943 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 259.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 21.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 350.00M | 2024-03-27 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | ProceedsFromPaymentsForOtherFinancingActivities | Proceeds from (Payments for) Other Financing Activities | USD | -15,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008166 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 98.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 68.95M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-08 | 0000950170-24-093308 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 174,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 257,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 155,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -111.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 9.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 2.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | RelatedPartyTransactionAmountsOfTransaction | Related Party Transaction, Amounts of Transaction | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008166 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 83.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043943 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 768,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 4.50M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 2.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -591.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 21.21M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-036814 |
| us-gaap | SecurityDeposit | Security Deposit | USD | 800,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 21.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.906 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.043 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 30,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 5.35 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 8.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 9.57 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-071907 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 7.64 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-071907 |
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 115,054 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024150 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043943 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 287.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.073 | 2021-10-22 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008166 | |
| us-gaap | StockholdersEquityOther | Stockholders' Equity, Other | USD | 27,000 | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | StockIssued1 | Stock Issued | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 6,635 | 2023-01-01 | 2023-03-31 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125428 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 215.30M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008166 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 136,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 38,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 39.09M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | TemporaryEquityAccretionToRedemptionValueAdjustment | Temporary Equity, Accretion to Redemption Value, Adjustment | USD | 10.94M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0000950170-22-004425 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 128.08M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0000950170-22-004425 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2021-11-02 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-021302 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 10.00M | 2021-11-02 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-021302 | |
| us-gaap | TreasuryStockCommonShares | Treasury Stock, Common, Shares | shares | 6.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | TreasuryStockCommonValue | Treasury Stock, Common, Value | USD | 39.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued | Unrecognized Tax Benefits, Interest on Income Taxes Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 | |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 39.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-130401 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 1.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 91.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 29.21M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009719 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 91.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452636 |